Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Aug 2, 2018
Click on the links below to view results for the 2018 third fiscal quarter: View document online PDF file of BD 2018 third fiscal quarter results About BD BD is one of the largest global medical...
-
Jul 26, 2018BD® AbSeq Assay Enables Deeper Understanding of Role Individual Cells Play in the Immune System
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial release of the BD(®) AbSeq assay to analyze protein expression at the...
-
Jul 12, 2018
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2017 Sustainability Performance Update that focuses on four key strategic areas that...
-
Jul 9, 2018everlinQ(TM) endoAVF System Receives FDA De Novo Marketing Authorization
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of TVA Medical, Inc., a company that develops...
-
Jun 27, 2018
Alexandria, VA., June 27, 2018 – In an effort to improve evidence-based care in Free and Charitable Clinics using point-of-care testing results, BD (Becton, Dickinson and Company) (NYSE: BDX) in...
-
Jun 18, 2018Visit BD Booth #9 and 10 to Learn how the Most Common Invasive Procedure doesn’t Need to be One of the Most Complex
Copenhagen, June 20, 2018 - During the 5th annual World Congress on Vascular Access (WoCoVA) being held June 20-22 in Copenhagen, BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global...
-
Jun 4, 2018BD Pyxis(TM) ES Refrigerator Expands Enterprise-wide Medication Management Solutions from BD to Improve Refrigerated Medication Management and Security
BD, Helmer Scientific Collaborate to Introduce First Fully Integrated Refrigerated Automated Dispensing Solution BD Pyxis(TM) ES Refrigerator Expands Enterprise-wide Medication Management...
-
May 3, 2018
Click on the links below to view results for the 2018 second fiscal quarter: View document online PDF file of BD 2018 second fiscal quarter results About BD BD is one of the largest global medical...
-
Apr 27, 2018Alberto Mas to Lead Medical Segment;
BD Names Three Executives to Segment Leadership Roles Alberto Mas to Lead Medical Segment; Patrick Kaltenbach to Lead Life Sciences Segment; Bill Tozzi to Lead Interventional Segment on Interim Basis
-
Apr 26, 2018New Cell Sorter Extends BD's Robust Portfolio of Flow Cytometry Research Solutions
BD Launches BD FACSymphony(TM) S6 High Parameter Cell Sorter to Enable Sorting of Rare Cell Types New Cell Sorter Extends BD's Robust Portfolio of Flow Cytometry Research Solutions FRANKLIN LAKES,...
-
Apr 19, 2018BD Synapsys(TM) Microbiology Informatics Solution Among New Offerings Shown at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
BD Unveils Suite of Diagnostic Informatics and Automation Innovations BD Synapsys(TM) Microbiology Informatics Solution Among New Offerings Shown at European Congress of Clinical Microbiology and...
-
Mar 22, 2018
BD Updates Instructions for Use for Certain BD Vacutainer® Blood Collection Tubes FRANKLIN LAKES, N.J., March 22, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading...
-
Mar 5, 2018New BD Survey Conducted by HIMSS Analytics® Reveals Heightened Need for Seamless Integration of Disparate Technologies during Medication Transit
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will demonstrate its comprehensive approach to integrated, enterprise medication management to help...
-
Feb 20, 2018CE-IVD labeled PAXgene® Blood ccfDNA tube will be available in Western Europe
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial availability of the CE-IVD marked PAXgene(®) Blood ccfDNA tube within...
-
Feb 13, 2018The BD Onclarity(TM) HPV Assay can detect 14 high-risk HPV types and provide additional information to guide physician decision-making
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received pre-market approval from the U.S. Food and Drug Administration...
-
Feb 6, 2018
Click on the links below to view results for the 2018 first fiscal quarter: View document online PDF file of BD 2018 first fiscal quarter results About BD BD is one of the largest global medical...
-
Feb 6, 2018- As reported, revenues of $3.080 billion increased 5.4 percent, or 3.7 percent on a currency-neutral basis, which includes an estimated 110 basis point adverse impact from the previously disclosed change in the U.S. dispensing business model.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $3.080 billion for the first fiscal quarter ended December 31,...
-
Jan 15, 2018New Test Provides Diagnostic Results Up to 10 Times Faster Than Traditional Tests
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, along with Check-Points Health B.V., announced today that the companies obtained CE Mark for a...
-
Jan 12, 2018
BD (Becton, Dickinson and Company) (NYSE: BDX) issued the following statement in response to receiving a warning letter from the U.S. Food and Drug Administration for its Preanalytical Systems...
-
Dec 29, 2017
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of C. R. Bard, Inc. (NYSE: BCR), creating a new health...
-
Dec 28, 2017
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement regarding today's clearance by the Ministry of Commerce of the People's...
-
Dec 22, 2017
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement regarding today's clearance by the U.S. Federal Trade Commission (FTC)...
-
Dec 11, 2017
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has established a Product Security Partnership Program that emphasizes collaboration...
-
Dec 4, 2017Experience the Advantage of Complete Medication Management at #ASHP17 BD Booth 721
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today revealed several technology innovations to further optimize the entire medication management...
-
Nov 16, 2017New BD HealthSight(TM) Platform for Enterprise Medication Management Takes System-Wide Approach to Make Medication Management Safer, Simpler and Smarter
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will launch its latest advancement in comprehensive medication management, BD HealthSight(TM) platform...